GENENTOX LABORATORIES LLC NPI 1538686597

NPI Details

GENENTOX LABORATORIES LLC is a clinical medical laboratory in Santa Ana, CA. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. GENENTOX LABORATORIES LLC NPI is 1538686597. The provider is registered as an organization entity type.
The provider Is Doing Business As Nova Diagnostics Labs.

The provider's business location address is:

2001 E 1ST ST STE 109
SANTA ANA, CA
ZIP 92705-020
Phone: (833) 668-2522
Fax: (833) 668-2329

The provider's authorized official is Kimberly Mendez .
The authorized official title is Owner and has the following contact phone number (714) 310-0922.

The CLIA number assigned to this NPI record is 05D0871568 - independent with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source (HCPCS:G2024)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Detection test by nucleic acid for multiple types influenza virus, each additional influenza virus type or sub-type (HCPCS:87503)
• Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique (HCPCS:87634)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique (HCPCS:87498)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Hemoglobin a1c level (HCPCS:83036)
• Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets (HCPCS:87507)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Automated urinalysis test (HCPCS:81003)

The enumeration date for this NPI number is 8/29/2017 and was last updated on 3/20/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: